KEVIN TANG - 12 Sep 2024 Form 3 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
Kevin Tang
Issuer symbol
AUPH
Transactions as of
12 Sep 2024
Transactions value $
$0
Form type
3
Filing time
23 Sep 2024, 16:05:18 UTC
Previous filing
02 Feb 2024
Next filing
18 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AUPH Common Shares 7.23M 12 Sep 2024 By LP F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AUPH Short Put Options (potential obligation to buy) 12 Sep 2024 Common Shares 3M $6.00 By LP F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Tang Capital Partners, LP ("TCP") beneficially owns 6,729,500 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCP III.
F2 Each put option is currently exercisable through the expiration date of the put option.
F3 The securities are beneficially owned by TCP.